The BETRECEP brand, founded in 2012 (United States), from 1125 sister brands and 17477 competing brands. BETRECEP is owned by Pfizer Inc, listed on the stock exchange of New York BETRECEP is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(BETRECEP)
over 5 years*
USD 19.11